Adam Marshall’s Post

In our winter #lifesciences outlook, we examine: ⇛ Easing funding concerns for #biotechs ⇛ Global clinical trial challenges ⇛ Resilient revenue trends for #medtech

In our winter #lifesciences outlook, we examine: ⇛ Easing funding concerns for #biotechs ⇛ Global clinical trial challenges ⇛ Resilient revenue trends for #medtech

Dive into the world of #BioTech and #Pharma with Rob Etherington, CEO of Clene Nanomedicine, Inc. as the 2024 JPMorgan Healthcare Conference takes place. Rob Etherington shares his journey with Clene Nanomedicine through the highs of early pandemic interest to the challenges of recent years. His candid reflections on investor confidence and capital management offer invaluable insights for anyone navigating this dynamic sector. Catch this enlightening interview as part of the 'Conversations Life Science Leaders Aren't Having' with Jeff Harmon in association with Russo Partners. #HealthcareInnovation #InvestorConfidence #JPM2024

Missed our recent webinar with Halloran Consulting Group, Inc. and DynamiCure Biotechnology on the value of specialized partner models in a data-rich environment? 💡 Check out this recap from Stephanie Emanuele on the key takeaways. ⤵️ ✔️The differences between traditional clinical research organizations (CROs) and newer data-focused specialty CROs ✔️Strategic advantages for trial sponsors in partnering with specialty service providers ✔️ Predictions for how the life sciences industry will evolve in 2024 and beyond Read it here: https://lnkd.in/d-tvZssk #LifeSciences #ClinicalData #ClinicalTrials

Russ Teichert, MBA, PhD, Founder and CEO at Scintillant Bioscience discussed "Outsourcing with Impact: How Scintillant Bioscience's CRO Services Drive Therapeutic Success" at #DDSS. This insightful presentation took place on #Day1 of #DDSS2024! Keep an eye out for further updates from #15thddss2024. #PharmaInnovation #UnlockPotential #summit2024 #staytunedformore."

💡Sponsors, before choosing a technology for sites, you must be honest with yourselves: Is it really a net reduction in burden or just another layer of complexity that drags out timelines? During our recent webinar "De-Risking Innovation in Small Pharma and Biotech Clinical Research - Possible or Not?," our panelist, Meraf Eyassu, hit the nail on the head with this topic.🔥 She emphasized the importance of appreciating the effort and time it takes to implement a technology. Sites are open to trying tech (74% according to Society for Clinical Research Sites (SCRS)), don't waste that goodwill with a hamfisted deployment. ⛔ Missed the webinar? Don’t worry! You can still catch all the valuable insights from our panel of seasoned professionals by watching the recording. Link in comments!👇 #clinicaloperations #clinops #clinicalresearch #clinicalstudy #pharmawebinar #biotechwebinar

In our winter #lifesciences outlook, we examine: ⇛ Easing funding concerns for #biotechs ⇛ Global clinical trial challenges ⇛ Resilient revenue trends for #medtech

In our winter #lifesciences outlook, we examine: ⇛ Easing funding concerns for #biotechs ⇛ Global clinical trial challenges ⇛ Resilient revenue trends for #medtech

We've thoroughly enjoyed the response to our LifeSci Consulting clinical outsourcing webinar with Nick Muir last week, with many across our network reaching out to share their perspectives, and to seek further insight. Ahead of our upcoming paper on how to manage clinical outsourcing, we thought we’d reshare some of the key points from last week's webinar, as well as a few more we’ve heard from key industry leaders in the last few days 👇 #drugdevelopment #biotech #innovation #clinicalresearch

The Better Biotech Growth webinar series continues! Join my colleague Mark Kastner this Wednesday as he shares key steps to align pricing and reimbursement with scientific value. Learn how to navigate the global P&MA landscape to ensure your product reaches the patients who need it most. Don’t miss out: skp.link/9rxv #BetterBiotechGrowth #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth